InvestorsHub Logo
Followers 36
Posts 20051
Boards Moderated 0
Alias Born 07/10/2015

Re: madg post# 40609

Tuesday, 03/05/2024 10:04:28 AM

Tuesday, March 05, 2024 10:04:28 AM

Post# of 41186
Notice you arent denying Zimmer is in fact a stakeholder. If you think the statement is a lie or half truth then dont imply it is and just come out and say it. Otherwise youre just employing methods of disinformation which you definitely did in your previous post. Attacking the messenger and not the content of their message is just disinformation. Before you say thats what im doing, no, its the content of your message which employs methods of disinformation.

https://www.ethosdebate.com/lies-rhetoric-4-18-rules-disinformation/

2019 was the last time their products were used together (After Zimmer hired Dr Lal the Si3n4 coatings expert - Dec 2018), that we know about, you're forgetting the use of Si3n4 coating on Zimmer's acetabular cup. Furthermore you arent touching on the fact that Zimmer's (family of companies) has had an inside man at Sintx since the company was founded. First it was Dr Hofmann (cofounder), then Dr Link (Chairman for 11 years before passing), now Dr Bal. This is no different than the people Eli Lilly had with Amylin. The founder of Amylin just sold a company to Eli Lilly then started Amylin. 1994, company goes public and two former executives from Eli Lilly are on the board. Then one of those two executives becomes Chairman/CEO, Joseph Cook. Its the exact same concept going on here. Yes, Eli Lilly did not acquire Amylin in the end but it still used Amylin for its strategic benefit trading it to Bristol Myers and acquiring Bristol Myers partner in ImClone instead (2008). Bristol Myers acquired Amylin 2012. both transactions had Mr iCahn in the middle who removed all Eli Lilly board members before selling Amylin to Bristol.

One way or another Zimmer will use Sintx for its benefit. In my view, it needs Si3N4. Of course this depends on them maintaining and desire to increase their position in ortho as well as the continued objective to diversify.

Per the most recent presentation:

ARTHROPLASTY (Silicon Nitride)
Renewed interest in silicon nitride’s use
as a femoral head and acetabular cup
.


The specific products (sub-components) mentioned here are the ones that used Zimmer IP for testing/development.

https://ir.sintx.com/company-information/presentations

========================================

Silicon Nitride, a Close to Ideal Ceramic Material for Medical Application

examples of their medical applications that relate to spinal, orthopedic and dental implants, bone grafts and scaffolds, platforms for intelligent synthetic neural circuits, antibacterial and antiviral particles and coatings, optical biosensors, and nano-photonic waveguides for sophisticated medical diagnostic devices are all covered in the research reviewed herein. The examples provided convincingly show that silicon nitride is destined to become a leader to replace titanium and other entrenched biomaterials in many fields of medicine.


https://www.mdpi.com/2571-6131/4/2/16/htm

========================================

Electromagnetic fields, metal implant corrosion, and dis-ease it causes


https://i.imgur.com/nLg7SXT.jpg

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172932779

Could it be that there is a strategy to distract people away from looking at the basic data?
Is all this an exercise to create more and more forum verbiage to drown out any serious discussion of evidence?

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SINT News